protein arrays
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
Israeli Startup OncoHost Eyeing 2022 Commercial Launch of Immunotherapy Response Prediction Test
Premium
The firm is validating its proteomics- and machine learning-based Prophet platform and setting up US operations in anticipation of a commercial launch next year.